{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:53:56Z","timestamp":1770749636416,"version":"3.50.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.transproceed.2013.02.099","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T01:52:41Z","timestamp":1366768361000},"page":"982-985","source":"Crossref","is-referenced-by-count":13,"title":["Hepatitis B \u201c360\u201d"],"prefix":"10.1016","volume":"45","author":[{"given":"M.L.","family":"Schilsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2013.02.099_bib1","first-page":"652","article-title":"Seroprevalence of hepatitis B and C among oncology patients in Turkey","volume":"29","author":"Kose","year":"2011","journal-title":"J Health Popul Nutr."},{"key":"10.1016\/j.transproceed.2013.02.099_bib2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2013.02.099_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"AASLD practice guidelines: chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2013.02.099_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol."},{"key":"10.1016\/j.transproceed.2013.02.099_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.transproceed.2013.02.099_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/jlts.2000.6446","article-title":"Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation","volume":"6","author":"Dodson","year":"2000","journal-title":"Liver Transplant."},{"key":"10.1016\/j.transproceed.2013.02.099_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20981","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results","volume":"13","author":"Schiff","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.transproceed.2013.02.099_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1872-034X.2012.01020.x","article-title":"Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation","volume":"43","author":"Ueda","year":"2013","journal-title":"Hepatol Res."},{"key":"10.1016\/j.transproceed.2013.02.099_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20981","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results","volume":"13","author":"Fox","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.transproceed.2013.02.099_bib10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2009.07.047","article-title":"Trends in waiting list registration for liver transplantation for viral hepatitis in the United States","volume":"137","author":"Kim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2013.02.099_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2013.02.099_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10620-011-2013-3","article-title":"Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure","volume":"57","author":"Dao","year":"2012","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.transproceed.2013.02.099_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.21998","article-title":"Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review","volume":"16","author":"Saab","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.transproceed.2013.02.099_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/TP.0b013e31824e3db4","article-title":"Hepatitis B-positive donors in renal transplantation: increasing the deceased donor pool","volume":"94","author":"Pilmore","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2013.02.099_bib15","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.transproceed.2013.02.099_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2011.09.016","article-title":"Liver transplantation from HbsAg+ donors: A safe way to expand the donor pool","volume":"56","author":"Loggi","year":"2012","journal-title":"J Hepatol."},{"key":"10.1016\/j.transproceed.2013.02.099_bib17","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1600-6143.2009.02707.x","article-title":"Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: a prospective nonrandomized controlled study from a single centre","volume":"9","author":"Jiang","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1016\/j.transproceed.2013.02.099_bib18","first-page":"1","article-title":"Updated CDC Recommendations for the Management of Hepatitis B Virus-Infected Health-Care Providers and Students","volume":"61","year":"2012","journal-title":"MMWR"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T20:11:25Z","timestamp":1595707885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0041134513002881"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.02.099","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}